-
公开(公告)号:US11845771B2
公开(公告)日:2023-12-19
申请号:US17418579
申请日:2019-12-26
申请人: GLYCOMIMETICS, INC.
发明人: John L. Magnani , John M. Peterson , Arun K. Sarkar , Yusufbhai U. Vohra , Indranath Ghosh , Jason Nogueira
IPC分类号: C07H19/056
CPC分类号: C07H19/056
摘要: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin, galectin-3, or E-selectin and galectin-3 to ligands are disclosed. For example, heterobifunctional inhibitors of E-selectin and galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
-
公开(公告)号:US09796745B2
公开(公告)日:2017-10-24
申请号:US14752056
申请日:2015-06-26
申请人: GlycoMimetics, Inc.
IPC分类号: A61K31/7034 , C07H15/207 , A61K45/06 , C07H15/26
CPC分类号: C07H15/207 , A61K31/7034 , A61K45/06 , C07H15/26 , C09C1/62
摘要: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selection antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
-
公开(公告)号:US20160289257A1
公开(公告)日:2016-10-06
申请号:US15182819
申请日:2016-06-15
申请人: GlycoMimetics, Inc.
发明人: John L. Magnani , Arun K. Sarkar
IPC分类号: C07H15/207 , C07H15/26
CPC分类号: C07H15/207 , A61K47/55 , C07H15/26
摘要: Compounds, compositions and methods are provided for use to inhibit infection by human immunodeficiency virus (HIV). More specifically, the present invention relates to glycomimetic compounds that inhibit HIV infection, and uses thereof.
摘要翻译: 提供化合物,组合物和方法用于抑制人免疫缺陷病毒(HIV)的感染。 更具体地,本发明涉及抑制HIV感染的糖模拟化合物及其用途。
-
公开(公告)号:US11548908B2
公开(公告)日:2023-01-10
申请号:US16957793
申请日:2018-12-28
申请人: GLYCOMIMETICS, INC.
IPC分类号: C07H15/207 , C07H15/26
摘要: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin, galectin-3, or E-selectin and galectin-3 to ligands a disclosed. For example, heterobifunctional inhibitors of E-selectin and galectin-3 are described and pharmaceutical compositions comprising at least one such agent is described.
-
公开(公告)号:US10519181B2
公开(公告)日:2019-12-31
申请号:US15531951
申请日:2015-12-01
申请人: GlycoMimetics, Inc.
IPC分类号: C07H15/26 , C07H15/207 , C07H3/06
摘要: Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells in the blood are disclosed. For example, heterobifunctional compounds that inhibit both E-selectins and CXCR4 chemokine receptors are described and pharmaceutical compositions comprising at least one of the same.
-
公开(公告)号:US20150284420A1
公开(公告)日:2015-10-08
申请号:US14439462
申请日:2013-10-31
申请人: GLYCOMIMETICS, INC.
IPC分类号: C07H15/24 , A61N5/10 , C07H15/203
CPC分类号: C07H15/24 , A61N5/10 , C07H15/203 , C07J17/005 , C07J41/0011 , C07J41/0055 , C07J41/0061
摘要: Provided herein are E-selectin antagonist therapeutic agents and improvements thereto and compositions comprising these E-selectin antagonists. Methods are also provided for using these E-selectin antagonist therapeutic agents to treat and/or prevent diseases and disorders treatable by inhibiting binding of an E-selectin to an E-selectin ligand. Also provided herein improvements to E-selectin antagonist glycomimetic compounds that improve the oral bioavailability of the glycomimetic compounds.
摘要翻译: 本文提供了E-选择素拮抗剂治疗剂及其改进,以及包含这些E-选择蛋白拮抗剂的组合物。 还提供了使用这些E-选择蛋白拮抗剂治疗剂治疗和/或预防通过抑制E-选择素与E-选择素配体的结合可治疗的疾病和病症的方法。 本文还提供了改善糖模拟化合物的口服生物利用度的E-选择素拮抗剂糖模拟化合物的改进。
-
公开(公告)号:US11878026B2
公开(公告)日:2024-01-23
申请号:US17522378
申请日:2021-11-09
申请人: GLYCOMIMETICS, INC.
IPC分类号: A61K31/7036 , A61K45/06
CPC分类号: A61K31/7036 , A61K45/06
摘要: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, E-selectin antagonists are described and pharmaceutical compositions comprising at least one of the same.
-
公开(公告)号:US11332491B2
公开(公告)日:2022-05-17
申请号:US16995237
申请日:2020-08-17
申请人: GLYCOMIMETICS, INC.
IPC分类号: A61K31/7034 , A61K45/06 , C07H15/207 , C09C1/62 , C07H15/26
摘要: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
-
9.
公开(公告)号:US20150110808A1
公开(公告)日:2015-04-23
申请号:US14367561
申请日:2012-12-21
申请人: GLYCOMIMETICS, INC.
IPC分类号: C07H15/207 , A61K45/06 , C07H15/26 , A61K31/7034
CPC分类号: C07H15/207 , A61K31/7034 , A61K45/06 , C07H15/26 , C09C1/62
摘要: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
摘要翻译: 提供使用E-选择蛋白拮抗剂的方法和组合物用于治疗和预防通过抑制E-选择素与E-选择蛋白配体的结合可治疗的疾病和病症。 本文描述的是E-选择蛋白拮抗剂,包括例如可用于治疗癌症的方法中的糖模拟化合物,抗体,适体和肽,以及治疗和预防转移,抑制癌细胞渗入骨髓,减少或抑制 癌细胞与包括骨髓细胞在内的内皮细胞的粘附,以及抑制血栓形成。
-
公开(公告)号:US11987598B2
公开(公告)日:2024-05-21
申请号:US17724585
申请日:2022-04-20
申请人: GLYCOMIMETICS, INC.
IPC分类号: A61K31/7034 , A61K45/06 , C07H15/207 , C07H15/26 , C09C1/62
CPC分类号: C07H15/207 , A61K31/7034 , A61K45/06 , C07H15/26 , C09C1/62
摘要: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.
-
-
-
-
-
-
-
-
-